{"url_path":"/sec/shph/8-k/2026-07-01/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1757499/0001493152-26-031375-index.html","accession_number":"0001493152-26-031375","cik":"0001757499","ticker":"SHPH","issuer_name":"Shuttle Pharmaceuticals Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1757499/0001493152-26-031375-index.html","primary_entity_key":"0001757499","primary_entity_name":"Shuttle Pharmaceuticals Holdings, Inc."},"word_count":87,"has_tables":true,"body_markdown":"**Item\n9.01 Financial Statements and Exhibits.**\n\n \n\n(d)\nExhibits\n\n \n\n**Exhibit\nNo.**\n \n**Description**\n\n99.1\n \n[Press Release, dated June 25, 2026](ex99-1.htm)\n\n99.2\n \n[Press Release, dated June 26, 2026](ex99-2.htm)\n\n104\n \nCover\nPage Interactive Data File (embedded within the inline XBRL document)\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\n \nSHUTTLE\nPHARMACEUTICALS HOLDINGS, INC.\n\nDated:\nJune 30, 2026\n \n \n\n \nBy:\n*/s/\nRyan Trasolini           *\n\n \nName:\nRyan\nTrasolini\n\n \nTitle:\nCo-Chief\nExecutive Officer"}